Methotrexate intolerance in rheumatoid arthritis: Prevalence, risk factors and impact on treatment adherence

Key Points

• Methotrexate intolerance significantly affects treatment adherence in patients with rheumatoid arthritis, leading to potential worsened outcomes.
• The study identifies key risk factors including age and prior treatment experiences that correlate with intolerance.
• Observational analysis assesses the prevalence of methotrexate intolerance and its implications for patient management.
• Highlighting the need for tailored treatment plans may improve adherence and overall outcomes for affected individuals.